|Bid||0.0880 x 38103100|
|Ask||0.0890 x 63288200|
|Day's range||0.0870 - 0.0900|
|52-week range||0.0320 - 0.1900|
|Beta (5Y monthly)||2.68|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Clinical stage synthetic cannabinoid company Botanix Pharmaceuticals Limited has today published positive data from a world first human clinical study, examining the safety, tolerability and efficacy of its BTX 1801 antimicrobial product for the eradication of Staphylococcus Aureus (Staph).
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...